Mariposa Therapeutics
PrivateLast Round
Seed
Mar 11, 2026
Total Funding Raised
$1M
Company Overview
Mariposa Therapeutics is a biotechnology company developing a first-in-class small molecule, MP5219, as a topical treatment for Epidermolysis Bullosa Simplex (EBS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mariposa Therapeutics Comparables
Compare Mariposa Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioMendics | 83% | |
| Paradigm Therapeutics, Inc. | 77% | |
| Aegle Therapeutics Corp | 76% |
Mariposa Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 11, 2026 |
Mariposa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Development Bank of Wales | Seed |
| DEBRA Research gGmbH | Seed |
Mariposa Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mariposa Therapeutics's valuation, stock price, and market status.
Is Mariposa Therapeutics a public or private company?
Mariposa Therapeutics is a private company.
What is the current stock price of Mariposa Therapeutics?
Mariposa Therapeutics is a private company, so its shares have no public market price. Caplight tracks Mariposa Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mariposa Therapeutics worth (valuation)?
Valuation information for Mariposa Therapeutics is not publicly available.
Can I buy Mariposa Therapeutics stock?
Mariposa Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mariposa Therapeutics's last funding round?
Mariposa Therapeutics's most recent funding round was Seed on March 11, 2026.
Who are the main investors in Mariposa Therapeutics?
Key investors in Mariposa Therapeutics include Development Bank of Wales.
Will Mariposa Therapeutics IPO soon?
No public IPO plans have been announced for Mariposa Therapeutics.
How can I track Mariposa Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Mariposa Therapeutics's shares on secondary markets.